Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus.
AUTOR(ES)
Schloemer, R H
RESUMO
Neuraminidase treatment of mouse mammary tumor virus, Rauscher murine leukemia virus, and Mason-Pfizer monkey virus resulted in loss of their capacity to inhibit hemagglutination of influenza virus. Hemagglutination-inhibition activity of these RNA tumor viruses could be restored by in vitro resialylation catalyzed by sialyl transferase. The major glycoprotein in the intact envelope of desialylated and, to some extent, native virions could be specificallly labeled in vitro with CMP-(14C) sialic acid. These studies further characterize the individual glycoproteins of mouse mammary tumor virus, Rauscher murine leukemia virus, and Mason-Pfizer monkey virus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=515612Documentos Relacionados
- RNA subunit structure of Mason-Pfizer monkey virus.
- Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins.
- Serological and Structural Properties of Mason-Pfizer Monkey Virus Isolated from the Mammary Tumor of a Rhesus Monkey
- Retrovirus D/New England and its relation to Mason-Pfizer monkey virus.
- Effect of tunicamycin on cell fusion induced by Mason-Pfizer monkey virus.
